Literature DB >> 18708168

The role of innate immunity in the induction of autoimmunity.

David S Pisetsky1.   

Abstract

The autoimmune diseases are a diverse group of conditions characterized by abnormal B and T cell reactivity in association with autoantibody production. Among these diseases, systemic lupus erythematosus (SLE) is notable for the expression of antibodies to DNA, with these antibodies representing diagnostic markers. While mammalian DNA is immunologically inert, DNA from bacteria can potently stimulate the innate immune system, activating both toll-like receptors (TLRs) as well as non-TLR internal receptors. Since the sera of normal humans contain antibodies specific for bacterial DNA, this molecule appears to be immunogenic during infection. In pre-autoimmune mice, immunization with bacterial DNA can induce anti-DNA autoantibody production, suggesting a role in initiating this response. The immune properties of DNA are mutable, however, since mammalian DNA can acquire immunological activity when bound to certain proteins or anti-DNA antibodies to form immune complexes. In SLE, these immune complexes can drive the production of interferon by plasmacytoid dendritic cells, thereby intensifying autoimmunity. Together, these observations suggest that DNA can induce innate as well as adaptive immune responses and promote the pathogenesis of SLE because of its intrinsic immunostimulatory activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708168     DOI: 10.1016/j.autrev.2008.07.028

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  36 in total

1.  Do we need new autoantibodies in lupus?

Authors:  R Hal Scofield
Journal:  Arthritis Res Ther       Date:  2010-05-28       Impact factor: 5.156

2.  Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells.

Authors:  Ravichandran Panchanathan; Hongzhu Liu; Yuet-Kin Leung; Shuk-mei Ho; Divaker Choubey
Journal:  Mol Cell Endocrinol       Date:  2015-08-12       Impact factor: 4.102

Review 3.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

4.  Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.

Authors:  Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

Review 5.  Intracellular DNA recognition.

Authors:  Veit Hornung; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

6.  Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs).

Authors:  Hideyuki Yanai; Shiho Chiba; Tatsuma Ban; Yukana Nakaima; Takashi Onoe; Kenya Honda; Hideki Ohdan; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

7.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

8.  Nucleic acid-binding polymers as anti-inflammatory agents.

Authors:  Jaewoo Lee; Jang Wook Sohn; Ying Zhang; Kam W Leong; David Pisetsky; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 9.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

10.  Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus.

Authors:  You-Hyun Lee; Jung-Yoon Choe; Sung-Hoon Park; Yong-Wook Park; Shin-Seok Lee; Young-Mo Kang; Eon-Jeong Nam; Won Park; Seong-Ryul Kwon; Sang-Cheol Bae; Yun-Jung Kim; Chang-Hee Suh; Hyoun-Ah Kim; Nam Wook Hur; Jisoo Lee
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.